AmCham Pharmaceutical Committee Luncheon
Healthcare policy decisions will ultimately affect patients’ lives. Therefore, patients have the right to play a meaningful role in developing healthcare policies. Engaging patients in health policy decision-making helps to ensure that policies reflect the needs of patients and caregivers. More attention must be given to the views of users and beneficiaries of healthcare – the patients themselves – and to the organizations that can effectively represent them – the patients’ organizations. Robust mechanisms must be created and enforced so that patients play appropriate roles in the decision-making process with their views listened to and acted upon.
AmCham is delighted to invite Dr. Julie Louise Gerberding, Executive Vice President and Chief Patient Officer, MSD & Co., Inc., to discuss the global trends of patient involvement in healthcare policy. During this presentation, Dr. Gerberding will cover:
- Areas in which patient involvement occurs – including but not restricted to clinical trials design, the regulatory process and HTA evaluation.
- Patient advocacy capacity building – patients can be empowered to be involved in health policy making.
- Case Sharing – advanced countries’ practices of patient involvement in health policy decision-making.
Julie Louise Gerberding
Executive Vice President and Chief Patient Officer,
Strategic Communications, Global Public Policy, & Population Health
MSD & Co., Inc.
Dr. Gerberding is Executive Vice President and Chief Patient Officer, Strategic Communications, Global Public Policy, and Population Health at MSD & Co., Inc. As Chief Patient Officer, Dr. Gerberding leads efforts to engage with patients and patient organizations to bring their perspectives into MSD to help inform company decisions. She represents MSD globally on patient-related matters. In addition, she is building new initiatives designed to accelerate MSD’s ability to contribute to improved population health, a measure increasingly valued by consumers, health organizations, and communities.
Dr. Gerberding was US CDC Director from 2002 to 2009. She led the CDC through more than 40 emergency responses to public health crises, including anthrax bioterrorism, SARS, and natural disasters. Dr. Gerberding received her undergraduate and M.D. degrees from Case Western Reserve University.
Dr. Gerberding has received more than 50 awards and honors, including the United States Department of Health and Human Services (DHHS) Distinguished Service Award for her leadership in responses to anthrax bioterrorism and the September 11, 2001 attacks. In 2018, she was selected as the Healthcare Businesswomen Association’s Woman of the Year and received the Lifetime Achievement Award from eyeforpharma. Previously, Dr. Gerberding was named to Forbes Magazine’s 100 Most Powerful Women in the World in 2005 through 2008 and to TIME Magazine’s 100 Most Influential People in the World in 2004.